Sitagliptin phosphate intermediates exporters in India
Sitagliptin phosphate intermediates exporters in India
A.R.Life Sciences are the popular choice for Sitagliptin phosphate intermediates exporters in
India. Sitagliptin phosphate is a popular medication used in the treatment of diabetes. Our
product is available in powder form at a competitive market price with a minimum quantity of
1000 gms.
Sitagliptin phosphate is used to treat Type -2 Diabetes. It works by increasing the
amount of insulin production in the body. It is an oral medication and is generally prescribed for
long-term treatment. Regular prescribed use of this medication is suggested to manage the
condition. It is recommended to be consumed along with diet and exercise for the best possible
results. The sitagliptin phosphate intermediates available with us are in powder form and have
a purity of 99.95%. They are in the form of a white crystalline and non-hygroscopic powder. The
product is soluble in water and slightly soluble in methanol and insoluble in isopropanol. We
have a production capacity of 600 kg per month and have stock ready for delivery. For the best
quality intermediates, trust A.R.Life Sciences, the leading Sitagliptin phosphate intermediates
exporters in India.
Sitagliptin Phosphate CAS No 762240-92-6 is a dipeptidyl peptidase-4 inhibitor. Januvia (Sitagliptin Phosphate) drug effectively works in type 2 diabetes by slowing the inactivation of incretin hormones. With scientific name 3-(tri fluoro methyl)-5, 6, 7, 8-tetra hydro–(1,2,4) Triazolo [4,3-a]-pyrazine HCl and molecular formula C16H15F6N5O•H3PO4•H2O, this is widely added to several medical formulations. With molecular weight of 523.32, this pharmaceutical intermediate comes in the form of a white to off-white, crystalline and non-hygroscopic powder. It is soluble in water, slightly soluble in methanol and insoluble in isopropanol.
764667-65-4:
- Product Features
- Advantages
- Applications
- Specifications
- Form: Powder
- Minimum order quantity: 100gram
- Categories: Pharma intermediates, Pharma API, Pharmaceutical intermediates, Pharmaceutical API, Active Pharmaceutical Ingredients
- Usage/Application: Commercial
- Manufacturer: A. R. Life sciences Pvt Ltd.
- Used in the manufacturing of final API, Active pharmaceutical ingredients
- Cancer (Bendamustine intermediates, Imatinib intermediates)
- Cardiovascular (Clopidogrel bisulphate intermediate & API)
- Anti-Coagulant (Dabigatran intermediates & API, CamostatMesylate intermediates & API)
- Leukemia (Dasatinib intermediates)
- Pain (Elagolix intermediate)
- Gaucher disease (Eliglustat intermediates)
- Osteoporosis (Ibandronate intermediate)
- Cystic fibrosis (Ivacaftor intermediates)
- Hyperuricemia (Lesinurad intermediate)
- Urinary Incontinence (Mirabegron, Solifenacin intermediates)
- Nausea & vomiting (Ondansetron intermediates)
- Anti-Psychotic (Paliperidone/Risperidone, Quetiapine intermediates)
- Acute Diarrhoea (Racecadotril intermediates)
- Deep vein thrombosis (Rivaroxaban intermediate)
- Type 2 Diabetes (Sitagliptin intermediates)
- NSAID (Etodolac API)
- Antibiotic (Sparfloxacin API)
- Anti-Arrhythmic agent (Adenosine API)
- Anti-Lipemic (Rosuvastatin calcium API)
- Iron chelator (Deferasirox)
- Purity, Grade
Sitagliptin Phosphate Intermediates Specifications :
Intermediate | CAS No’s | API/End Use | Purity |
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5- trifluorophenyl)but-2-en-2-amine. | 767340-03-4 | Sitagliptin Phosphate | |
4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one | 764667-65-4 | Sitagliptin Phosphate | NLT 97% |